Episodes 22
Avg. Duration 14m
Activity Sporadic
Since Jul 2024
Latest Episode Oct 2025

Publishing Details

Schedule
Monthly
Format
Episodic
Consistency
27%
Hosting
feeds.megaphone.fm

Contact & Outreach

About This Podcast

Thought leaders from the field present insights from dementia research, clinical practice, and caregiving that will help you maximize the quality of life and well-being of your patients

Explore Statistics

Recent Episodes

Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

Oct 09, 2025 11m

Ana C. Pereira, MD, Associate Professor, Icahn School of Medicine at Mount Sinai, New York, NY, discusses key takeaways about the impact of patient lifestyle modifications on brain health, updates in…

The Brain Health Navigator: A Novel Program to Improve Alzheimer Disease Care

Oct 08, 2025 14m

Gregory E. Cooper, MD, PhD, Director, Memory Center, Norton Neuroscience Institute, Louisville, KY, outlines the Brain Health Navigator program as a strategy to streamline dementia care pathways,…

Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

Sep 09, 2025 21m

This episode explores groundbreaking qualitative research from the University of Pennsylvania on patient and caregiver perspectives in Alzheimer disease. Dr. Katie Auriemma, Perelman School of…

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

May 01, 2025 17m

In this episode, we are joined by entrepreneur and television personality, Barbara Corcoran. While many know Barbara for her business acumen and dynamic presence on Shark Tank, fewer may know the…

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Mar 21, 2025 20m

Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neuroscientist focused on…

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

Feb 25, 2025 11m

Nicolas Villain, MD, PhD, Associate Professor of Neurology, Sorbonne University, Paris, France, discusses the International Working Group’s updated diagnostic criteria for the diagnosis and staging…

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Jan 25, 2025 16m

Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discusses the experimental oral…

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

Dec 19, 2024 10m

Sarena Ho, Health Insurance Specialist at the CMS Innovation Center, provides an overview on the Guiding an Improved Dementia Experience (GUIDE) Model, which helps physicians provide coordinated care…

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

Nov 19, 2024 15m

Gary E. Gibson, PhD, Professor of Neurosciences, Burke Neurological Institute, Weill Cornell Medicine, White Plains, NY, details his research related to metabolic changes associated with Alzheimer…

BrainCheck as a Digital Cognitive Assessment Tool

Nov 08, 2024 7m

Kim Rodriguez, CEO of BrainCheck, provides an overview of the company's cognitive assessment plan and how clinicians can use these tools in practice. Learn more about your ad choices. Visit…

Kramer, Van Dyck

Sep 27, 2024 12m

Lynn D. Kramer, MD, FAAN, Chief Clinical Officer, Deep Human Biology Learning at Eisai and a member of the Eisai Executive Committee, and Christopher van Dyck, MD, Professor of Psychiatry, Neurology,…

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

Sep 21, 2024 10m

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker…

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

Sep 21, 2024 17m

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker…

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

Sep 21, 2024 8m

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker…

Labcorp's Biomarker Testing for Alzheimer Disease

Sep 16, 2024 12m

Joseph M. Volpe, MD, Discipline Director, Clinical Neuroscience, Labcorp, discusses biomarker testing for Alzheimer disease and dementia,, including current offerings, reimbursement, and future…

What Neurologists Should Know About End-of-Life Care Discussions

Jul 19, 2024 20m

Dan Morhaim, MD, board-certified emergency medicine and internal medicine physician, and former 24-year Maryland State Legislator, highlights the importance of discussing end-of-life care issues with…

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

Jul 15, 2024 22m

Virginia Man-Yee Lee, PhD, who serves as the John H. Ware 3rd Endowed Professor in Alzheimer's Research at the University of Pennsylvania Perelman School of Medicine, the Director of the Center for…

Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

Jul 15, 2024 9m

Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss new findings on baseline characteristics about…

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

Jul 15, 2024 8m

Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss recent data analyzing the real-world implications of…

Emerging Therapeutic Targets for Alzheimer Disease

Jul 15, 2024 14m

Howard Fillit, MD, geriatrician, neuroscientist, and Chief Science Officer and Co-Founder of the Alzheimer's Drug Discovery Foundation, discusses the importance of research into new therapeutic…

Frequently Asked Questions

How many episodes does Expert Voices in Dementia have?

Expert Voices in Dementia has published 22 episodes since July 2024, covering topics in Education, Health & Fitness.

Is Expert Voices in Dementia still active?

Expert Voices in Dementia is currently sporadic with new episodes monthly. Average episode length is 14m.

How do I contact Expert Voices in Dementia for sponsorship or guest appearances?

Sign up on Grep.FM to access contact details for Expert Voices in Dementia, including email and social media links.

Similar Podcasts